KRYSTAL BIOTECH INC. - COMMON STOCK

Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer

18 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech Announces Initial Clinical Update for Rare Respiratory Disease Programs KB408 and KB407 Including Early Clinical Evidence of Gene Delivery to the Lung of AATD Patients and Increase in Lung AAT to Therapeutic Levels

12 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa

09 дек 2024 15:15:00 Источник Nasdaq GlobeNewswire

Krystal Biotech to Present at Upcoming Investor Conferences

27 ноя 2024 06:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech to Present at Stifel 2024 Healthcare Conference

12 ноя 2024 06:00:01 Источник Nasdaq GlobeNewswire

Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference

06 ноя 2024 06:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates

04 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024

28 окт 2024 06:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference

13 сен 2024 06:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference

06 сен 2024 06:00:00 Источник Nasdaq GlobeNewswire

Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the Décolleté

28 авг 2024 06:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech Announces Second Quarter 2024 Financial Results and Provides Business Updates

05 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024

26 июл 2024 07:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference

05 июн 2024 06:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech to Present at the American Thoracic Society 2024 International Conference

15 май 2024 06:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech to Present at BofA Securities 2024 Health Care Conference

08 май 2024 06:00:01 Источник Nasdaq GlobeNewswire

Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates

06 май 2024 07:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting

02 май 2024 06:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024

26 апр 2024 06:00:00 Источник Nasdaq GlobeNewswire

Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung

22 апр 2024 06:00:00 Источник Nasdaq GlobeNewswire